Android app on Google Play

Credit Suisse Starts Pharmacyclics (PCYC) at Outperform

January 15, 2013 8:58 AM EST Send to a Friend
Get Alerts PCYC Hot Sheet
Price: $96.61 +1.11%

Rating Summary:
    14 Buy, 10 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 9 | New: 24
Trade PCYC Now!
Join SI Premium – FREE
Credit Suisse initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Outperform. PT $79.00.

For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.

Shares of Pharmacyclics closed at $65.15 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Credit Suisse

Add Your Comment